Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study

Background Cross-sectional reports suggest that statin users are less likely to have Alzheimer disease (AD). Prospective studies have provided inconsistent evidence. Moreover, it is unclear whether the association differs for lipophilic statins, those that could more easily pass the blood-brain b…